COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Carina Mihai, Rucsandra Dobrotă, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler
Topics & Concepts
MedicineTocilizumabInterstitial lung diseaseDiabetes mellitusInternal medicineHydroxychloroquinePolyarthritisDiseaseArthritisLungCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)EndocrinologySystemic Sclerosis and Related DiseasesDermatological and COVID-19 studiesCOVID-19 and healthcare impacts